Substituted amylose as a matrix for sustained drug release

Pharmaceutical Research

Volumn 16, Issue 9, 1999, Pages 1436-1440

  Chebli, Chafic ^a   Moussa, Iskandar ^a   Buczkowski, Stéphane ^a   Cartilier, Louis ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Direct compression; Polymer; Substituted amylose; Sustained drug release

Indexed keywords

AMYLOSE; HYLON 7; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL MODIFICATION; DRUG DESIGN; DRUG DOSAGE FORM; DRUG SOLUBILITY; MATRIX TABLET; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ACETAMINOPHEN; ALKANES; AMYLOSE; ANALGESICS, NON-NARCOTIC; BUTANES; CARCINOGENS; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EPOXY COMPOUNDS; HYDROXYLATION; MOLECULAR WEIGHT; POLYMERS; PROPANOLS; SOLUBILITY; TABLETS; WATER;

EID: 0032872445     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018963428219     Document Type: Article

References (19)

1. S. Ségot-Chicq, E. Teillaud, and N. A. Peppas. Les dispositifs à libération contrôlée pour la délivrance des principes actifs médica-menteux. I. Intérêt et applications. S.T.P. Pharma 1:25-36 (1985).
2. J. Kost and S. Shefer. Chemically modified polysaccharides for enzymatically-controlled oral drug delivery. Biomaterials 11: 695-698 (1990).
3. C. G. Biliaderis. The structure and interactions of starch with food constituents. Can. J. Physiol. Pharmacol. 69:60-78 (1991).
4. US Patents 3,622,677 and 4,072,535, R. W. P. Short and F. Verbanac. Starch Suitable for Direct Compression of Tablets, A. E. Staley Manufacturing Company, Decatur, Ill, U.S.A., 1978.
5. US Patent 4,369,308, P. C. Trubiano and N. J. Somerville. Low-Swelling Starches as Tablet Disintegrants, National Starch and Chemical Corporation, Bridgewater, NJ, U.S.A., 1983.
6. US Patent 3,034,911, I. K. Makee and W. Herbst. Tablet Disintegrants (1962).
7. M. Nakano, N. Nakazono, and N. Inotsume. Preparation and evaluation of sustained release tablets prepared with α-starch. Chem. Pharm. Bull 35:4346-4350 (1987).
8. P. Van Aerde and J. P. Remon. In-vitro evaluation of modified starches as matrices for sustained release dosage forms. Int. J. Pharm. 45:145-152 (1988).
9. J. Hermann and J. P. Remon. Modified starches as hydrophilic matrices for controlled oral delivery. II. In-vitro drug release evaluation of thermally modified starches. Int. J. Pharm. 56: 51-63 & 65-70 (1989).
10. J. Hermann and J. P. Remon. Modified starches as hydrophilic matrices for controlled oral delivery. III. Evaluation of sustained release of theophylline formulation based on thermal modified starch matrices in dogs. Int. J. Pharm. 63:201-205 (1990).
11. US Patent 5,603,956, M. A. Mateescu, Y. Dumoulin, L. Cartilier, and V. Lenaerts. Cross-linked Polyhydroxylic Material for Enzymatically Controlled Drug Release (1997).
12. US Patent 5,616,343, L. Cartilier, M. A. Mateescu, Y. Dumoulin, and V. Lenaerts, Cross-linked Amylose as a Binder/disintegrant in Tablets (1997).
13. US Patent 5,879,707, L. Cartilier, I. Moussa, C. Chebli, and S. Buczkowski. Substituted Amylose as a Matrix for Sustained Drug Release.
14. nd edition, 4:386-388 (1985).
15. E. A. Peterson and H. A. Sober. Chromatography of proteins. I. Cellulose ion-exchange adsorbents. J. Am. Chem. Soc. 78:751-755 (1956).
16. N. A. Peppas. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 60:110-111 (1985).
17. G. W. Sinclair and N. A. Peppas. Analysis of non-Fickian transport in polymers using a simplified exponential expression. J. Membrane Sci. 17:329-331 (1984).
18. N. A. Peppas and J. J. Sahlin. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int. J. Pharm. 57:169-172 (1989).
19. C. G. Biladeris, C. M. Page, and T. J. Maurice. Non-equilibrium melting of amylose-V complexes. Carbohydrate Polymers 6: 269-288 (1986).